FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/03/012596 [Registered on: 15/03/2018] Trial Registered Prospectively
Last Modified On: 15/03/2018
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Prospective Single Arm Two phases Observational study 
Study Design  Single Arm Study 
Public Title of Study   A study to detect the effect of operation related stress on urine filtration by kidneys in patient undergoing surgery for cancer and effect of increase in urine filtration on blood level of antibiotic drugs given during operation  
Scientific Title of Study   Augmented Renal Clearance in patients undergoing cancer surgery and its impact on pharmacokinetics of administered antibiotics. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
Project No 1970 V 2.0_9 FEB 2018  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sheila Nainan Myatra 
Designation  Professor 
Affiliation  Tata Memorial Center 
Address  Department of Anesthesia Critical care and Pain Tata Memorial Centre Dr E Borges Road Parel Mumbai

Mumbai
MAHARASHTRA
400012
India 
Phone  9820156070  
Fax    
Email  sheila150@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sheila Nainan Myatra 
Designation  Professor 
Affiliation  Tata Memorial Center 
Address  Department of Anesthesia Critical care and Pain Tata Memorial Centre Dr E Borges Road Parel Mumbai


MAHARASHTRA
400012
India 
Phone  9820156070  
Fax    
Email  sheila150@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sheila Nainan Myatra 
Designation  Professor 
Affiliation  Tata Memorial Center 
Address  Department of Anesthesia Critical care and Pain Tata Memorial Centre Dr E Borges Road Parel Mumbai


MAHARASHTRA
400012
India 
Phone  9820156070  
Fax    
Email  sheila150@hotmail.com  
 
Source of Monetary or Material Support  
Intramural Funds Tata Memorial Hospital, Parel Mumbai 400012 
 
Primary Sponsor  
Name  Tata Memorial Hospital  
Address  Dr E Borges Road, Parel, Mumbai 400012 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sheila Nainan Myatra  Tata Memorial Hospital  Room No 1 to 12A, Major peration theater complex, Main Building Second Floor, Department of Anesthesiology Critical care and Pain,Dr E Borges Road, Parel, 400012
Mumbai
MAHARASHTRA 
9820156070

sheila150@hotmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Cancer patients undergoing surgeries which will last for more than 3hrs,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1)Adult patients more than 18 years of age.
2)Patients admitted a day prior to surgery.
3)Surgeries lasting more than 3 hours.
4)Surgeries with routine intra-operative placement of arterial line.
5)Normal pre-operative renal functions (Creatinine clearance greater than 90 ml per min per 1.73 meter square)


 
 
ExclusionCriteria 
Details  Exclusion Criteria
1)Emergency Surgery.
2)Patient having pre-operative features suggestive of Systemic Inflammatory Response Syndrome (SIRS) / Sepsis.
2a.Temperature more than 38 degree Celsius (100.4 F) or less than 36 degree Celsius (96.6 F)
2b.Heart Rate more than 90 beats/minute
2c.WBC counts more than 12,000 per uL or less than 4000 per ul or more than 10% immature forms
2d.Respiratory rate more than 20 breaths per minute or paCO2 less than 32mmHg
3)Patients receiving pre-operative antibiotics.
4)Patients with calculated GFR less than 90 ml per min per 1.73 meter square

 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To establish if ARC is observed in patients undergoing major surgery  1.12 hrs prior surgery
2. just prior initiation of surgery
3. at time of wound closure after surgery 
 
Secondary Outcome  
Outcome  TimePoints 
To study the effect of ARC on pharmacokinetics of administered antibiotics.   After surgery 5 mins, 15 mins, 30 mins, 1 hr, 1.5 hrs, 2 hrs , 4 hrs, 6 hrs, 8 hrs and 12 hrs 
To study the association of inflammatory biomarker levels with the development of ARC.  1. one day prior the surgery
2. at the time of wound closure after surgery 
 
Target Sample Size   Total Sample Size="86"
Sample Size from India="86" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/04/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None Any 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Introduction

Augmented renal clearance (ARC) may be defined as an altered state of circulation that leads to an increased clearance of renally eliminated solutes with CrCl ≥ 130 mL/min/1.73 m2. The physiology behind ARC is not well understood. Recent studies have shown critically ill patients to frequently develop a hyperdynamic cardiovascular circulatory pattern as a consequence of systemic inflammatory response. High cardiac output leads to increased perfusion in different organs, including the kidneys. In this way, increases in the glomerular filtration rate could ensue, with subsequent enhanced renal elimination of circulating solutes.

Augmented renal clearance (ARC)[8] may significantly impact the successful application of many renally eliminated agents by promoting sub-therapeutic drug exposure [8,9]. Although specific data concerning drug CL in critical illness remains sparse, elevated urinary creatinine clearance (CLCR), as a marker of ARC, has been documented in sepsis[10], ventilator associated pneumonia[11], traumatic brain injury[12], burns[13], multi-trauma[14] and post-operatively[15]. Application of aggressive fluid resuscitation [25] and vasopressor support [26] further augments this process, leading to substantial changes in renal function. ARC in the critically ill is associated with some conditions, mostly trauma(4) and burns.(5) Nevertheless, its epidemiology, risk factors, and clinical characteristics have not been comprehensively investigated. Particularly, studies focused on general population patients are scarce.

Surgical stress is part of the systemic reaction to surgical injury which encompasses a wide range of endocrinological, immunological and haematological effects. There is activation of sympathetic nervous system and endocrine stress response. The inflammatory response related to surgery both surgical and anesthesia induced lead to release of cytokines which mediate and maintain the inflammatory response to tissue injury known as acute phase response. This inflammatory and sympathetic response that could produce similar effects as seen in ICU admitted patients. A study by Lin Mt et al assessed the impact of surgery on local and systemic responses of cytokines and adhesion molecules by measuring the levels of inflammatory markers prior to surgery and on post-operative days 1, 3 and 7. The authors demonstrated that circulating IL-6 and P-selectin increased after surgery while circulating ICAM-1 and E-selectin diminished post- surgery.(27)

Veenhof A. et al studied the surgical Stress Response and postoperative immune function in patients undergoing laparoscopy vs open surgery using IL-6 levels to predict the inflammatory response.(28)

Another study by Baigrie et al examined patients before, during and after major surgery, exploring the association between plasma cytokine levels namely IL-1b,IL-6, TNF-a and IFN-^, the clinical course and CRP response. They observed that the systemic IL-I beta and IL-6 response to surgical trauma increased with the severity of the surgical insult and an early, exaggerated IL-6 response was associated with the subsequent clinical development of major complications (29).

Similar studies on objectively assessing inflammatory response in cancer surgery are lacking.

In addition, rapidly fluctuating renal hemodynamic, constantly changing volume status of the patient and the fact that concept of ARC is not frequently applied in calculating GFR can lead to inadequate dosing of drugs in this setting. This may result in sub therapeutic dosing of antibiotics delivered intra-operatively which may impact post-operative infections. Hence, it is imperative to identify if there is ARC in patients undergoing surgery and if so, to modify the dose of commonly used antibiotics intra-operatively.

Apart from one study, currently underway, ARC PPS (Augmented renal clearance Point prevalence study) that is studying the prevalence of augmented renal clearance (i.e. a measured 8-hour urinary creatinine clearance >= 120 ml/min/1.73m²) in an adult non-critically ill abdominal and trauma surgery population, there is no study to the best of

 

our knowledge that has attempted to document ARC in non-critically ill patients going cancer surgery.

Detection of ARC

Based on the values of creatinine in the urine, measured creatinine clearance (Cr. Clr.m) would be estimated. Patients having Cr. Clr.m> 130ml/min/1.73 m2 would be categorised to have ARC.

At the end of the surgery, an additional blood sample would be collected to measure serum creatinine values. This value would then be used to assess calculated creatinine clearance. This would help draw a comparison between measured and calculated creatinine clearance values. As most of drug administration in post-operative period is based on calculated creatinine clearance values.

Methodology

This study will be conducted in two phases

Phase 1 Pilot study:- To Establish Augmented renal clearance phenomenon.

Phase 2 Main study:- To confirm ARC and to study effect of ARC on antibiotics pharmacokinetics.

Phase 1 Pilot Study.

This phase 1 of study would be a pilot clinical trial of 36 consecutive patients undergoing major thoraco-abdominal and orthopaedic surgeries.

Prior to the start of the main study, a pilot study and will be done to establish if ARC does exist in patients undergoing major surgeries.  Only after pilot study proves the presence of Augmented Renal Clearance in more than 10 % patients, phase 2 of the study will be started.

Pre-operative Part of Study

All patients who are admitted for above mentioned surgeries have baseline renal functions already performed. Based on the most recent creatinine values, creatinine clearance would be calculated using Cockcroft-Gault formulae. Patients with calculated GFR < 90 ml/min/1.73m2 would be excluded from the study.

Measured creatinine clearance will be calculated pre-operatively by collecting 12 hour urine sample of the patient upon admission of the patient to the ward. Patient will be provided container to empty urine and a 12 hour urine sample would be collected to measure pre-operative urine creatinine clearance. This sample would be sent for estimation of creatinine.

On the day of surgery

All patients will receive the treatment as a part of routine treatment protocol intra-operatively.

The induction and maintenance of anaesthesia and post-operative ICU management would be done routinely as per the decision of consultant OT and ICU anaesthetist respectively. We would collect blood samples (volume-3ml) just prior the surgery and at the time of closure for measuring serum creatinine (Crs).

All patients undergoing major surgeries have an Arterial catheter line and Foley’s catheter insertion as a routine protocol prior to starting the surgery. Blood will be collected from patient’s arterial line and patient will not be pricked intra-operatively for blood sampling. Intra-operatively foleys catheter is inserted in these patients as a routine procedure. After discarding initial urine sample collected in urobag just after foley insertion, rest of the urine will be collected at the end of the surgery and will be used for estimation of urine creatinine levels (Cru).

Sample Size

1.       Augmented renal clearance prevalence was 30% and 35% in 103 abdominal and 129 trauma surgery patients, respectively. (Augmented renal clearance in non–critically ill abdominal and trauma surgery patients is an underestimated phenomenon. Declercq Peter, Nijs Stefaan, DʼHoore André. s.l. : Journal of Trauma and Acute Care Surgery, 2016, Vol. 80.)

Considering the 30% prevalence prevalence of ARC in major abdominal and trauma surgeries and precision of 15% a total sample size 36 is required to confirm the ARC phenomenon.

Phase 2 Main Study

Phase 2 will be done to confirm Augmented Renal clearance and to study effect of ARC on antibiotics pharmacokinetics.

This phase 2 of study would be a clinical trial of 50 consecutive patients undergoing major thoraco-abdominal and orthopaedic surgeries. After confirming the effect of surgical stress on renal clearance and defining presence of the Augmented renal clearance in patient undergoing major thoraco-abdominal and orthopaedic surgeries phase 2 will study the effect of ARC on antibiotic blood level. For studying the pharmacokinetics of antibiotics following extra samples will be collected along with the urine and blood sample as mentioned in phase1.

Pre-operative Part of Study

An evening blood sample (3 mL) would be extracted from all the patient in plain vacutainer in the ward. This sample would be stored in a cold container and sent to ACTREC the next day for estimation of levels of cytokines IL1b, IL-6, TNF – alpha, IFN-^ and the CRP levels to detect extent of inflammatory response.

Measured creatinine clearance will be calculated pre-operatively by collecting 12 hour urine sample of the patient upon admission of the patient to the ward. Patient will be provided container to empty urine and a 12 hour urine sample would be collected to measure pre-operative urine creatinine clearance. This sample would be sent for estimation of creatinine.

 

On the day of surgery

All patients will receive the treatment as a part of routine treatment protocol intra-operatively.

The induction and maintenance of anaesthesia and post-operative ICU management would be done routinely as per the decision of consultant OT and ICU anaesthetist respectively. We would collect blood samples (volume – 3ml) just prior the surgery and for measuring serum creatinine (Crs). Also two samples each of 3 mL would be collected at the time of closure for measuring serum creatinine (Crs) and inflammatory biomarkers respectively. Urine would be collected preoperatively from a container provided to patient for urine collection and post operatively from an urometer after Foley’s catheter insertion intra-operatively.

All patients, as a part of routine protocol receive antibiotics prior to the incision intra-operatively. These antibiotics depend on unit protocol. Most commonly used antibiotic in thoracic and orthopaedic surgeries is Cefuroxime, gastrointestinal surgeries is Cefoperazone and sulbactam and gynaecological surgeries is Amoxicillin and clavulanic acid. These antibiotics as a part of routine protocol are repeated intra-operatively after 4 hours.

Pharmacokinetic analysis-

For cefuroxime (half life -1hr), we will collect samples at (t=0 mins) and then at 3 mins, 10 mins, 30 mins, 1 hr, 2 hrs , 3 hrs .After second dosage of antibiotic, samples will be collected at  (t=0 mins) and then at  3 mins, 10 mins, 30 mins, 1 hr, 2 hrs , 3 hrs, 4 hrs , 5 hrs and 6 hrs to capture the entire pharmacokinetic profile of the drug.

For cefoperazone-sulbactam ( half life- 1.6 hrs), we will collect samples at (t=0 mins) and then at  5 mins, 15 mins, 30 mins, 1 hr, 1.5 hrs and 2 hrs. After second dosage of antibiotic, samples will be collected at (t=0 mins) and then at  5 mins, 15 mins, 30 mins, 1 hr, 1.5 hrs, 2 hrs , 4 hrs, 6 hrs, 8 hrs and 12 hrs.

For amoxicillin and clavulanic acid, we will collect samples at (t=0 mins) and then at  5 mins, 15 mins, 30 mins, 1 hr, 1.5 hrs, 2 hrs, 3 hrs and 4 hrs. After second dosage of antibiotic, samples will be collected at (t=0 mins) and then at  5 mins, 15 mins, 30 mins, 1 hr, 1.5 hrs, 2 hrs ,3 hrs, 4 hrs, 8 hrs, and 10 hrs.

The samples will be collected in EDTA vacutainers stored in an icebox for transport to ACTREC. Samples would be stored at ACTREC in refrigerator at -20 o C temperature until analysis. Samples will be centrifuged at 3000rpm for 15 mins to separate plasma following which, estimation of cefuroxime, cefoperazone and amoxicillin levels will be done using LC-MS-MS technique.

The blood antibiotic levels would be used to estimate up to what duration intra-operatively MIC of antibiotic is maintained using standard bolus dosing protocol followed intra-operatively.

At the end of the surgery, an additional blood sample would be collected to measure serum creatinine values. This value would then be used to assess calculated creatinine clearance. This would help draw a comparison between measured and calculated creatinine clearance values. As most of drug administration in post-operative period is based on calculated creatinine clearance values.

Sample Size

Since this is a feasibility study, we shall assess 50 patients undergoing major surgery to detect the incidence of ARC.


 
Close